Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients

Open access
Bazeley, Jonathan, Bieber, Brian, Li, Yun, Morgenstern, Hal, de Sequera, Patricia, Combe, Christian, Yamamoto, Hiroyasu, Gallagher, Martin, Port, Friedrich K., Robinson, Bruce M. · 2011 · Clinical Journal of the American Society of Nephrology

Abstract

BACKGROUND AND OBJECTIVES: Measurement of C-reactive protein (CRP) levels remains uncommon in North America, although it is now routine in many countries. Using Dialysis Outcomes and Practice Patterns Study data, our primary aim was to evaluate the value of CRP for predicting mortality when measured along with other common inflammatory biomarkers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied 5061 prevalent hemodialysis patients from 2005 to 2008 in 140 facilities routinely measuring CRP in 10 countries. The association of CRP with mortality was evaluated using Cox regression. Prediction of 1-year mortality was assessed in logistic regression models with differing adjustment variables. RESULTS: Median baseline CRP was lower in Japan (1.0 mg/L) than other countries (6.0 mg/L). CRP was positively, monotonically associated with mortality. No threshold below which mortality rate leveled off was identified. In prediction models, CRP performance was comparable with albumin and exceeded ferritin and white blood cell (WBC) count based on measures of model discrimination (c-statistics, net reclassification improvement [NRI]) and global model fit (generalized R(2)). The primary analysis included age, gender, diabetes, catheter use, and the four inflammatory markers (omitting one at a time). Specifying NRI ≥5% as appropriate reclassification of predicted mortality risk, NRI for CRP was 12.8% compared with 10.3% for albumin, 0.8% for ferritin, and <0.1% for WBC. CONCLUSIONS: These findings demonstrate the value of measuring CRP in addition to standard inflammatory biomarkers to improve mortality prediction in hemodialysis patients. Future studies are indicated to identify interventions that lower CRP and to identify whether they improve clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.00710111

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 175

Metadata

Authors
Bazeley, J., Bieber, B., Li, Y., Morgenstern, H., de Sequera, P., Combe, C., Yamamoto, H., Gallagher, M., Port, F. K., & Robinson, B. M.
Venue
Clinical Journal of the American Society of Nephrology
Published
2011-10
Volume
6
Issue
10
Pages
2452-2461
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2149147910
Cited by
175
References
10
FWCI
5.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients. https://app.cochat.ai/papers/10.2215/cjn.00710111
The paper
Bazeley, J., Bieber, B., Li, Y., Morgenstern, H., de Sequera, P., Combe, C., Yamamoto, H., Gallagher, M., Port, F. K., & Robinson, B. M. (2011). C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.00710111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.